Supplementary Table 3 from Characterization of In Vivo Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance
收藏数据链接：
官方服务：
资源简介：
Summary of data from drug resistance evaluation
创建时间：
2017-11-01
